Brett Sandercock - Nov 10, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Nov 10, 2021
Transactions value $
-$507,050
Form type
4
Date filed
11/12/2021, 12:17 PM
Previous filing
Oct 12, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.95% $57.76 87.3K Nov 10, 2021 Direct F1
transaction RMD ResMed Common Stock Sale -$651K -2.5K -2.86% $260.58 84.8K Nov 10, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -10% $0.00 22.5K Nov 10, 2021 ResMed Common Stock 2.5K $57.76 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 46.9876 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.
F3 Represents date options first became exercisable. Options vest 1/3 per year.